Delivery Order SPE2DB20D1100-SPE2DB25FE2Y0
- Not listed
- The Defense Logistics Agency awarded a $2,176.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The award was made on April 23, 2025, with an ultimate completion date of April 24, 2025, and represents a non-competitive delivery order under the company's existing contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,176.72 for Mounjaro 10 mg/0.5 ml pen (0.5ml) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction for this diabetes medication under a larger contract vehicle. This award is a child delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,631.78 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025, under a firm fixed-price contract type with no set-aside designation. The product will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract, awarded on May 6, 2025, with an ultimate completion date of May 7, 2025, was competitively awarded without a set-aside designation under firm fixed-price terms. Performance will take place at the company's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,632.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen (0.5 ml), a diabetes medication. The order was competitively awarded with no set-aside designation and is scheduled for completion by October 27, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance, aligning with the company's role as a primary pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a $2,419.93 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract with an ultimate completion date of June 17, 2025 will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,897.78 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens (a diabetes medication) on September 3, 2025, with a completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a relatively small transaction within...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,499.68 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, with a completion date of November 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and is classified as a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,601.07 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen (0.5 mL), a diabetes treatment medication. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 22, 2025. This award was made on a competitive basis with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE2Y0Delivery Order
The Defense Logistics Agency awarded a $2,737.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-competitive delivery order executed under an existing contract vehicle. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems worldwide. AmerisourceBergen's contract portfolio with the Defense Logistics Agency demonstrates its established capability as a critical pharmaceutical distributor for federal medical procurement, supplying diverse therapeutic categories including diabetes treatments, neurological medications, pain management pharmaceuticals, and other essential medical supplies across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/26/25 |